Dipti Sareen

Dr. Dipti Sareen

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MMManuel Montalban-Lopez
Manuel Montalban-Lopez
TSThomas A. Scott
Thomas A. Scott
SRSangeetha Ramesh
Sangeetha Ramesh
IRImran R. Rahman
Imran R. Rahman
AHAuke J. van Heel
Auke J. van Heel
WDWilfred A. van der Donk
Wilfred A. van der Donk
This review provides a comprehensive update of the advances in discovery, biosynthesis, and engineering of ribosomally-synthesized and post-translationally modified peptides (RiPPs).

10 May 2002 in Biochemistry
Verified
Journal Article
Closed access
DSDipti Sareen
Dipti Sareen
MSMicah Steffek
Micah Steffek
GNGerald L. Newton
Gerald L. Newton
RFRobert C. Fahey
Robert C. Fahey

1 August 2017 in Talanta
Verified
Journal Article
Closed access
HTHimkusha Thakur
Himkusha Thakur
NKNavpreet Kaur
Navpreet Kaur
DSDipti Sareen
Dipti Sareen
NPNirmal Prabhakar
Nirmal Prabhakar

12 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMangal Singh
Mangal Singh
DSDipti Sareen
Dipti Sareen
Frequent use of antibiotics has led to the emergence of antibiotic resistance in bacteria. Lantibiotic compounds are ribosomally synthesized antimicrobial peptides against which bacteria are not able to produce resistance, hence making them a good alternative to antibiotics. Nisin is the oldest and the most widely used lantibiotic, in food preservation, without having developed any significant resistance against it. Having their antimicrobial potential and a limited number, there is a need to identify novel lantibiotics. Identification of novel lantibiotic biosynthetic clusters from an ever increasing database of bacterial genomes, can provide a major lead in this direction. In order to achieve this, a strategy was adopted to identify novel lantibiotic biosynthetic clusters by screening the sequenced genomes for LanT homolog, which is a conserved lantibiotic transporter specific to type IB clusters. This strategy resulted in identification of 54 bacterial strains containing the LanT homologs, which are not the known lantibiotic producers. Of these, 24 strains were subjected to a detailed bioinformatic analysis to identify genes encoding for precursor peptides, modification enzyme, immunity and quorum sensing proteins. Eight clusters having two LanM determinants, similar to haloduracin and lichenicidin were identified, along with 13 clusters having a single LanM determinant as in mersacidin biosynthetic cluster. Besides these, orphan LanT homologs were also identified which might be associated with novel bacteriocins, encoded somewhere else in the genome. Three identified gene clusters had a C39 domain containing LanT transporter, associated with the LanBC proteins and double glycine type precursor peptides, the only known example of such a cluster is that of salivaricin. This study led to the identification of 8 novel putative two-component lantibiotic clusters along with 13 having a single LanM and 3 with LanBC genes. Putative lantibiotic clusters identified here hold the potential for the discovery of novel lantibiotic(s).

19 January 2017 in Journal of Biosciences
Verified
Journal Article
Closed access
PDF file
MSMangal Singh
Mangal Singh
SCSandeep Chaudhary
Sandeep Chaudhary
DSDipti Sareen
Dipti Sareen

7 March 2017 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
PSPriya Saini
Priya Saini
DSDipti Sareen
Dipti Sareen